跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,600 条关于
“ABL1 myristoyl pocket”
全部
1,600
临床试验
1,127
药物
73
机构
9
资讯
391
去年
Novartis Receives CDSCO Approval for Phase IIIb Trial of Asciminib in Chronic Myeloid Leukemia
6个月前
FDA Accepts PBPK Modeling to Replace Ten Clinical Trials for CML Drug Asciminib
去年
FDA Approves Scemblix (asciminib) for First-Line Treatment of Chronic Myelogenous Leukemia
5年前
FDA Approves Scemblix (asciminib) for Chronic Myeloid Leukemia with Novel Mechanism
4年前
Scemblix Receives Positive CHMP Opinion for CML Treatment After TKI Failure
4年前
Scemblix Receives European Commission Approval for CML Treatment After TKI Failure
4年前
Scemblix Receives Positive CHMP Opinion for CML Treatment After TKI Failure
去年
FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid Leukemia
3年前
Asciminib Demonstrates Durable Efficacy and Safety in Heavily Pretreated CML-CP Patients
去年
Non-ABL1 Mutations Impact Outcomes in Chronic Myeloid Leukemia
第 1 页,共 40 页
上一页
下一页